← Open Payments lookup

BRITTANY DICKERT: Open Payments

NPI 1598165474 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,456 in 126 payments from 19 companies in 2025. Trend: 2023 $3,783 · 2024 $3,788 · 2025 $2,456

Food & beverage: $2,447Education: $9
CompanyPaymentsAmount
ABBVIE INC.26$470
PFIZER INC.18$362
Janssen Biotech, Inc.16$305
Takeda Pharmaceuticals U.S.A., Inc.14$255
GENZYME CORPORATION9$181
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$172
Gilead Sciences, Inc.5$124
Regeneron Healthcare Solutions, Inc.5$119
Madrigal Pharmaceuticals4$90
QOL Medical, LLC5$70

Products named: TREMFYA, DUPIXENT, VELSIPITY, RINVOQ, XIFAXAN, ENTYVIO, XELJANZ, LINZESS.

Industry payments across MD — which companies pay providers there.